The ACCP PBRN has received IRB approval for its first study through the American Academy of Family Physicians IRB. The feasibility study, titled “Medication Error Detection, Amelioration, and Prevention (MEDAP) in the ACCP PBRN,” will evaluate, document, and compare clinical pharmacist interventions that help reduce or eliminate medication errors and harms in a wide variety of practice settings using the ACCP PBRN model. The Frontiers Fund is funding this study. The specific aims of this project are to:

1. Evaluate the feasibility and acceptability of a practice-based project conducted within a national pharmacist PBRN;
2. Describe pharmacist documentation of medication safety and surveillance interventions reported by clinical pharmacists using the Cerner Discovere platform as the data collection instrument; and
3. Compare the reported pharmacist interventions among a variety of health care settings.

The ACCP Research Institute will host two 1-hour training sessions on the study featuring walk-throughs of our data collection system at the ACCP Spring Forum on Sunday, April 25, at 1:00 p.m. and on Monday, April 26, at 11:30 a.m. Both sessions will be held in Room 214 of the Charlotte Convention Center. Space is very limited. Join your fellow ACCP PBRN members as we work toward the rollout of our first project.